Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $50.5800 (0.28%) ($49.8300 - $50.9550) on Fri. Nov. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.1% (three month average) | RSI | 34 | Latest Price | $50.5800(0.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -1.7% a day on average for past five trading days. | Weekly Trend | BAX declines -3.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) BLOK(27%) XLK(21%) VT(20%) VUG(20%) HYG(18%) | Factors Impacting BAX price | BAX will decline at least -1.05% in a week (0% probabilities). UUP(-13%) VIXM(-12%) TLT(-8%) TIP(-1%) EWP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.05% (StdDev 2.1%) | Hourly BBV | -0.7 () | Intraday Trend | -0.6% | | | |
|
1 - 5 Day Possible Target | $46.69(-7.69%) | Resistance Level | $54.69 | 5 Day Moving Average | $52.21(-3.12%) | 10 Day Moving Average | $53.98(-6.3%) | 20 Day Moving Average | $54.69(-7.52%) | To recent high | -18.4% | To recent low | 0.3% | Market Cap | $25.805b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |